Literature DB >> 22073816

What it takes to defend deceptive placebo use.

Anne Barnhill1.   

Abstract

A complete defense of deceptive placebo use must address this ethical objection: deceptive placebo use violates patient autonomy, because deceiving a patient about the placebo nature of a proposed treatment prevents her from giving informed consent to the treatment. Unfortunately, this objection isn't always recognized and clearly disambiguated from other ethical concerns. I consider how well several bioethicists who write about placebo use have responded to, or evaded, this objection. I conclude that defenders of deceptive placebo use should, following the lead of Onora O'Neill, argue that deceptive placebo use is compatible with informed consent.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22073816     DOI: 10.1353/ken.2011.0015

Source DB:  PubMed          Journal:  Kennedy Inst Ethics J        ISSN: 1054-6863


  6 in total

1.  Placebo and deception: a commentary.

Authors:  Anne Barnhill; Franklin G Miller
Journal:  J Med Philos       Date:  2014-12-10

2.  Neurofeedback as placebo: a case of unintentional deception?

Authors:  Louiza Kalokairinou; Laura Specker Sullivan; Anna Wexler
Journal:  J Med Ethics       Date:  2021-09-14       Impact factor: 5.926

3.  Are open-Label Placebos Ethical? Informed Consent and Ethical Equivocations.

Authors:  Charlotte Blease; Luana Colloca; Ted J Kaptchuk
Journal:  Bioethics       Date:  2016-02-03       Impact factor: 1.898

4.  Ravines and sugar pills: defending deceptive placebo use.

Authors:  Jonathan Pugh
Journal:  J Med Philos       Date:  2014-12-10

Review 5.  Placebos as a Source of Agency: Evidence and Implications.

Authors:  Phoebe Friesen
Journal:  Front Psychiatry       Date:  2019-10-25       Impact factor: 4.157

6.  Effects of open-label placebos in clinical trials: a systematic review and meta-analysis.

Authors:  Melina von Wernsdorff; Martin Loef; Brunna Tuschen-Caffier; Stefan Schmidt
Journal:  Sci Rep       Date:  2021-02-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.